Moffitt Research Identifies Crucial Biomarker for Predicting Effectiveness of KRASG12C Inhibitors in Lung Cancer ...
TAMPA, Fla. (Jan. 31, 2025) — In the riveting landscape of oncology, a groundbreaking study conducted by Moffitt Cancer Center has emerged, potentially revolutionizing the way medical professionals approach treatment strategies for lung cancer, …